Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Myant Accelerates Precision Healthcare with Acquisition of Bitnobi Inc.

This image opens in the lightbox

News provided by

Myant Corp.

16 Jan, 2025, 15:59 GMT

Share this article

Share toX

Share this article

Share toX

TORONTO, Jan. 16, 2025 /PRNewswire/ -- Myant, a global leader in advanced materials and connected health solutions, proudly announces the acquisition of Toronto-based technology innovator, Bitnobi Inc. Spun out of York University with the support of Toronto Innovation Acceleration Partners (TIAP), Bitnobi specializes in privacy-protected data-sharing software. Their groundbreaking platform facilitates secure collaboration between data owners and consumers without compromising raw data—a critical capability in today's healthcare landscape.

This marks Myant's fourth strategic acquisition in just six months, each one bolstering its platform with new technologies, capabilities, and markets. Together, these moves are driving Myant closer to its bold mission: empowering people to live younger for longer through proactive, personalized, and precision healthcare solutions.

The acquisition of Bitnobi fills a critical gap in the third pillar of Myant's strategy: safe and secure data sharing. By integrating Bitnobi's patented platform, Myant advances its ability to create a "digital human replica," an innovative approach to personalizing healthcare through insights generated from its smart material solution

"Myant is building the equivalent of a fiber-optic connection to the human body which enables a true digital replica," said Tony Chahine, Myant's founder and CEO. "We aim to connect the human operating system—its rhythms, signals, and unique needs—use advanced materials, AI, and sensing to deliver proactive and preventative care. This acquisition strengthens our ability to provide precise and personalized support that goes beyond reactive healthcare."

Expanding the Boundaries of Data Sharing and Collaboration

Through this acquisition, Myant enhances its capacity to share and utilize healthcare data responsibly and effectively. The company will not only be able to share its proprietary data with researchers and clinicians but also securely access third-party data while respecting governance protocols.

The partnership will also drive new data-sharing collaborations across Canada and internationally, unlocking valuable health insights and fostering innovation. "Bitnobi enables us to create seamless, secure pathways for data sharing that respect privacy while opening new doors for healthcare innovation," Chahine added.

A Proven Platform for the Future of Precision Healthcare

Since its founding in 2016, Bitnobi has supported significant initiatives, including Canada's Digital Health and Discovery Platform (DHDP). By enabling secure management of digital health data, Bitnobi is accelerating precision medicine for cancer and other diseases. Now, as part of Myant, Bitnobi's expertise in big data, cloud computing, and cybersecurity will amplify innovation across Myant's textile computing, smart materials, and data integration efforts.

Hassan Jaferi, CEO of Bitnobi, emphasized the alignment of the two companies' missions: "Myant has created a global innovation hub in Toronto, where over 200 scientists, engineers, and researchers are driving breakthroughs in connected health. Joining forces will amplify our collective impact, ensuring that innovation in Canada's technology and healthcare sectors continues to thrive."

Shaping the Future of Healthcare

This acquisition underscores Myant's commitment to proactive, precision healthcare. By integrating advanced materials, intelligent interfaces, and secure data sharing, Myant is not only redefining health and aging but also positioning itself as a global leader in innovation.

Together, Myant and Bitnobi are shaping a future where healthcare is proactive, personalized, precise and preventative—empowering individuals to live healthier, longer, and more independent lives.

About Myant
Myant is leading a new era of evolution where AI guardians enhance human capabilities through textile interfaces that function like a connected second skin. This second skin – made possible by groundbreaking advanced materials – blends naturally into our everyday lives, setting a new standard for seamless interaction with the digital world.

About Bitnobi
Bitnobi Inc. is a technology startup focused on the commercialization of a privacy protected, data sharing platform. Bitnobi was spun out of research from Dr. Marin Litoiu's laboratory at York University with full support from the Toronto Innovation Acceleration Partners and Innovation York. Headquartered in Toronto, Canada, Bitnobi has also received assistance from the Natural Sciences and Engineering Research Council of Canada, Ontario Centres of Innovation, Seneca College, National Research Council of Canada's Industrial Research Assistance Program, Rogers Cybersecure Catalyst, MaRS Discovery District and Canada's Digital Health and Discovery Platform.

For more information, please contact:
Charles Andreo
info@myant.ca
www.myant.ca

Logo - https://mma.prnewswire.com/media/2569573/5120589/Myant_Logo.jpg

Modal title

Also from this source

Myant Launches Care360: AI-Powered Precision Cardiac Assessments Delivered Directly to Patients and Physicians

Myant Launches Care360: AI-Powered Precision Cardiac Assessments Delivered Directly to Patients and Physicians

Cardiovascular disease (CVD) is the world's leading cause of death, claiming 19 million lives annually and costing billions. 9 in 10 Canadians have...

Myant Brings the Future of Disease Prevention to Arab Health 2025

Myant Brings the Future of Disease Prevention to Arab Health 2025

At Arab Health 2025, Myant will showcase its mission to enable human-centric, precise, and preventive care through continuous connection, a vision...

More Releases From This Source

Explore

Computer & Electronics

Computer & Electronics

Health Care & Hospitals

Health Care & Hospitals

Data Analytics

Data Analytics

Data Analytics

Data Analytics

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.